Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)

PHASE4CompletedINTERVENTIONAL

Enrollment

169

Participants

Timeline

Start Date

August 11, 2009

Primary Completion Date

January 9, 2014

Study Completion Date

January 14, 2014

Conditions

ThrombocytopeniaIdiopathic Thrombocytopenic Purpura

Interventions

BIOLOGICAL

romiplostim

Romiplostim administered by subcutaneous injection